secwatch.observer — SEC 8-K summary
======================================

Issuer:     KYNTRA BIO, INC. (KYNB)
CIK:        0000921299
Form:       8-K
Filed at:   2024-10-03T23:59:59+00:00
Accession:  0000950170-24-112331
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.02
LLM model:  deepseek-v4-flash:cloud@v2

FibroGen terminates headquarters lease, accelerates expiration to Dec 31, 2024, with $10M settlement
--------------------------------------------------------------------------------

- Entered Lease Termination Agreement with landlord ARE-San Francisco No.43 Owner, LLC.
- Lease at 409 Illinois Street, San Francisco, ends Dec 31, 2024 (previously later date).
- $10M settlement includes past rent, operating costs, lease modification payment, and security deposit (LC).
- FibroGen not responsible for further rent or operating costs after termination.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/921299/000095017024112331/0000950170-24-112331-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/921299/000095017024112331/fgen-20240927.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-112331

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer